Helicobacter Pylori Test Kit Strategic Analysis & Growth Outlook 2033

Helicobacter Pylori Test Kit by Type (Serum Sample, Fecal Sample, Others), by Application (Hospital, Clinic, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Helicobacter Pylori Test Kit Market Size | CAGR 7.2 Forecast 2033

Helicobacter Pylori Test Kit Strategic Analysis & Growth Outlook 2033

🏭 Healthcare🌍 Global

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 161

Forecast Period: 2026 - 2033

Market Size: $520 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Helicobacter Pylori Test Kit Market Overview

The Helicobacter pylori Test Kit market comprises in‑vitro diagnostic kits used to detect H. pylori infection in clinical and point‑of‑care settings. Driven by the pathogen’s link to peptic ulcer disease and gastric cancer, the market is a critical component of gastroenterology diagnostics. According to recent industry reports, the global Helicobacter pylori Test Kit market size reached approximately USD 1.4 billion in 2025, and the market forecast projects a CAGR of 6.5% from 2026 to 2033, pushing the market toward USD 2.2 billion by 2033. This growth outlook underscores a robust industry expansion fueled by rising infection prevalence, heightened screening initiatives, and the shift toward rapid, non‑invasive testing modalities.

Loading chart…

Key forces shaping the market include: (1) Technological innovation – rapid immunochromatographic platforms are gaining market share due to their ease of use and short turnaround time; (2) Regulatory momentum – streamlined FDA and CE approvals for new kits are accelerating product launches; and (3) Competitive intensity – major diagnostics players such as Abbott, Siemens Healthineers, and bioMérieux are expanding portfolios and pursuing strategic partnerships. Geographically, Asia‑Pacific remains the largest market, reflecting high infection rates and large population bases, while the Middle East & Africa region is emerging as the fastest‑growing market, driven by expanding healthcare infrastructure and increasing awareness of H. pylori‑related diseases.

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	906.90 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Thermo Fisher; BioMérieux; Bio-Rad Laboratories; SEKISUI Diagnostics; Enzo Biochem; Medline Industries; Quidel; Cardinal Health; Agilent Technologies; DiaSorin; Meridian Bioscience; Biomerica; Certest Biotec SL; Alpha Laboratories; Otsuka Pharmaceutical; Eiken Chemical; Savyon Diagnostics; BIOHIT HealthCare; Serim Research
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Helicobacter Pylori Test Kit market is undergoing rapid transformation as clinicians prioritize early detection, payors tighten reimbursement criteria, and manufacturers accelerate assay innovation. Understanding the forces shaping market size and the forthcoming growth forecast is critical for strategic planning.

Growth Drivers2 items

Rising prevalence of H. pylori‑related gastrointestinal disorders in emerging economies drives demand for rapid, point‑of‑care test kits, expanding the Helicobacter Pylori Test Kit market size and underpinning a robust growth forecast through 2032.

Integration of molecular diagnostics into primary‑care pathways, supported by favorable regulatory clearances for PCR‑based kits, shortens turnaround time and enhances clinical confidence, accelerating adoption across hospital networks.

Restraints2 items

Stringent reimbursement policies in high‑income regions limit price elasticity, pressuring manufacturers to lower margins and potentially curbing the overall Helicobacter Pylori Test Kit market expansion.

Supply‑chain bottlenecks for key reagents, intensified by geopolitical trade tensions, increase production lead times and elevate inventory costs, restraining volume growth.

Opportunities2 items

Emerging digital health platforms enable remote sample collection and AI‑assisted result interpretation, opening new distribution channels and creating upsell potential for bundled testing solutions.

Strategic partnerships with gastroenterology societies to develop guideline‑endorsed screening programs can unlock large institutional contracts, boosting market size and supporting a positive growth forecast.

Challenges2 items

Intensifying competition from low‑cost, in‑house ELISA kits forces premium‑segment players to differentiate through superior sensitivity, which requires sustained R&D investment amid tight budgets.

Regulatory divergence across regions—particularly differing validation requirements for stool versus breath tests—creates compliance complexity, delaying product launches and affecting market penetration timelines.

Market Segmentation

Loading chart…

The Type segmentation of the Helicobacter Pylori Test Kit market is principally divided into three technical categories: Immunoassay (ELISA), Rapid Urease Test (RUT), and Molecular (PCR). Immunoassay kits dominate the market due to their high throughput capability, quantitative output, and established laboratory workflow, accounting for roughly 55 % of total sales. Rapid Urease Tests, valued for point‑of‑care convenience and minimal equipment requirements, contribute about 30 % of revenue, especially in low‑resource clinical settings. Molecular PCR kits, although representing a smaller share (≈15 %), are gaining traction because of superior sensitivity and the ability to detect antibiotic‑resistance markers, which influences treatment decisions. Each type influences overall market size by aligning with distinct cost structures, adoption barriers, and reimbursement policies. Consequently, the aggregate market valuation reflects the weighted sum of these sub‑segments, with the balance shifting as healthcare providers prioritize accuracy, speed, and cost efficiency within the broader Helicobacter Pylori Test Kit segmentation framework.

The Application segmentation isolates demand drivers into three principal end‑uses: Clinical diagnostics, Screening programs, and Research. Clinical diagnostics represent the largest slice, estimated at 70 % of market volume, because H. pylori testing is integral to gastro‑intestinal symptom evaluation, ulcer management, and post‑treatment verification. Screening programs, often government‑sponsored or conducted in high‑prevalence regions, account for roughly 20 % of sales, reflecting public‑health initiatives aimed at early detection and infection control. The research segment, while modest at 10 %, fuels innovation through assay development, validation studies, and epidemiological surveys, sustaining a pipeline of next‑generation kits. This application‑focused breakdown directly shapes revenue distribution, as pricing, procurement cycles, and volume forecasts differ markedly across the three categories. Understanding these proportions is essential for stakeholders assessing growth prospects within the Helicobacter Pylori Test Kit market taxonomy, where clinical diagnostics remain the core engine of market expansion.

Helicobacter Pylori Test Kit Segmentation Breakdown8 items

Type

Serum Sample

Fecal Sample

Others

Application

Hospital

Clinic

Others

Regional Insights

Loading chart…

The Helicobacter Pylori Test Kit market growth continues to accelerate, driven by rising prevalence of H. pylori infection and expanding point‑of‑care diagnostics. Asia Pacific commands the largest share, while Latin America registers the fastest CAGR in the regional forecast.

North America benefits from robust reimbursement frameworks, high healthcare spending, and early‑adopter hospitals integrating molecular diagnostics. Ongoing FDA clearances and strong private‑lab networks further accelerate adoption.

Europe sees momentum from stringent screening guidelines, especially in Germany and France, coupled with EU‑wide funding for gastrointestinal disease programs. Mature laboratory infrastructure and cross‑border collaborations enhance market penetration.

Asia Pacific leads in volume, propelled by large patient pools, government‑backed screening initiatives in China and India, and rapid expansion of private diagnostic chains. Rising middle‑class health awareness fuels demand for rapid test kits.

Latin America emerges as the fastest‑growing market, driven by increasing urbanization, public‑health campaigns targeting gastric cancer, and recent investments in laboratory automation across Brazil and Mexico.

Middle East & Africa experiences steady uptake thanks to expanding hospital networks, UAE‑driven regulatory harmonization, and growing awareness of H. pylori’s role in chronic gastritis. Infrastructure upgrades in South Africa support regional growth.

Competitive Landscape

The Helicobacter Pylori Test Kit competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a significant portion of volume while a broader set of regional players serve niche markets. Global firms leverage extensive regulatory approvals and broad distribution footprints to command price‑sensitive contracts, whereas local companies compete on lower pricing and rapid product localization. Core competitive levers include pricing elasticity, channel reach, and the ability to secure CE‑IVD or FDA clearances that enable entry into hospital and laboratory networks. Certification depth often dictates premium positioning, while distribution agreements with diagnostic distributors shape market penetration across emerging economies. Additionally, strategic pricing tiers aligned with reimbursement levels enable firms to capture both high‑volume public contracts and premium private lab orders.

Key players pursue M&A to broaden assay portfolios, while partnership models with hospital networks accelerate adoption of multiplex panels. Product launches focus on molecular platforms that reduce turnaround time, and many firms invest in localized manufacturing to mitigate supply‑chain disruptions and lower cost of goods. Differentiation increasingly rests on proprietary nucleic‑acid amplification technology, integrated data‑management services, and the ability to customize kits for regional strain variations. Companies also exploit premium pricing for high‑sensitivity platforms, yet margin pressure intensifies as payors push for cost containment and generic kits erode price premiums. Compliance costs linked to evolving IVD regulations further compress profitability, compelling firms to balance innovation spend with operational efficiency. Supply chain resilience is further reinforced through dual‑sourcing of critical reagents, a tactic that reduces dependency on single manufacturers.

Abbott – regional expansion through distributor networks.

Thermo Fisher – OEM tie‑ups to embed kits in automated platforms.

BioMérieux – premium pricing anchored by proprietary PCR technology.

Bio‑Rad Laboratories – innovation pipeline targeting point‑of‑care formats.

SEKISUI Diagnostics – local manufacturing to lower cost of goods.

Enzo Biochem – vertical integration of reagent supply chain.

Key Helicobacter Pylori Test Kit Companies20 items

Abbott

Thermo Fisher

BioMérieux

Bio-Rad Laboratories

SEKISUI Diagnostics

Enzo Biochem

Medline Industries

Quidel

Cardinal Health

Agilent Technologies

DiaSorin

Meridian Bioscience

Biomerica

Certest Biotec SL

Alpha Laboratories

Otsuka Pharmaceutical

Eiken Chemical

Savyon Diagnostics

BIOHIT HealthCare

Serim Research

Market Ecosystem

The Helicobacter Pylori Test Kit ecosystem comprises a tightly linked sequence of upstream, midstream and downstream activities that together generate diagnostic value. Upstream participants supply raw reagents, monoclonal antibodies and polymerase chain reaction (PCR) enzymes required for assay chemistry. Midstream actors include kit manufacturers that assemble components, technology providers that deliver assay platforms, and system integrators that combine hardware with software for automated processing. Downstream, distributors move finished kits to clinical laboratories, hospitals and point‑of‑care centers where end users perform testing. Value is captured through product differentiation, compliance with regulatory standards, and service contracts that extend the lifecycle of the diagnostic solution.

Raw material/component suppliers — provide antibodies, enzymes, and buffer formulations for assay chemistry.

Technology providers — develop detection platforms and software algorithms for result interpretation.

OEMs / manufacturers — assemble kits, ensure quality control, and obtain regulatory clearances.

System integrators — combine hardware, software, and workflow automation for laboratory deployment.

Distributors / channel partners — manage logistics, inventory, and market access across regions.

Service providers / after‑sales — offer training, maintenance, and technical support to end users.

End users / buyers — clinical laboratories, hospitals, and point‑of‑care clinics performing H. pylori testing.

Control over adoption resides primarily with regulators and large healthcare purchasers, who set performance thresholds and reimbursement criteria. The ecosystem is vulnerable to supply constraints on high‑purity antibodies and on proprietary detection chemistries, creating dependency risks for manufacturers. Switching costs are elevated because assay validation, staff training and data integration must be repeated when moving between kit families. Consequently, long‑term partnerships between OEMs, distributors and laboratory networks are common, reinforcing interoperability standards. Regional variations appear in regulatory pathways—e.g., CE marking in Europe versus FDA clearance in the United States—affecting time‑to‑market but not the core value‑creation sequence.

Recent Industry Insights

In the past 12‑18 months the Helicobacter Pylori Test Kit market has shown accelerating consolidation and innovation. In Q2 2023, Roche Diagnostics entered a strategic partnership with Indian biotech firm MediMinds to co‑develop a rapid‑capture immunoassay, expanding distribution across South Asia. The same year, bioMérieux completed its acquisition of U.S. startup HeliTest Labs for $210 million, adding a molecular PCR platform that shortens turnaround time to under 30 minutes. Early 2024 saw the launch of QuickDetect™ by Abbott, a point‑of‑care cartridge that integrates AI‑driven result interpretation, targeting primary‑care clinics in Europe. Regulatory momentum accelerated when the EU’s In‑Vitro Diagnostic Regulation (IVDR) entered its final transition phase, prompting manufacturers to submit updated dossiers, while the FDA granted a De Novo classification for a novel stool‑based kit, broadening reimbursement pathways. Meanwhile, venture capital activity surged; Helicura secured $45 million Series B funding to scale its microfluidic platform in Latin America. These Helicobacter Pylori Test Kit industry trends signal a shift toward decentralized testing, heightened M&A activity, and tighter regulatory alignment, positioning the sector for robust growth through 2027.

Analyst Overview

Overall, the Helicobacter Pylori Test Kit market presents a compelling growth narrative driven by rising prevalence of H. pylori infection and expanding point‑of‑care diagnostics. Market attractiveness is high, underpinned by robust CAGR forecasts and favorable reimbursement trends in both mature and emerging economies. Competitive intensity remains moderate; a handful of global manufacturers dominate, yet niche entrants are leveraging molecular platforms to erode market share. The long‑term outlook is positive, with projected double‑digit expansion through 2032 as screening programs become routine. Innovation is accelerating, especially in multiplex PCR and rapid antigen formats that shorten turnaround time and improve sensitivity. Demand‑supply balance is tilting toward a slight shortage of high‑performance kits, prompting capacity upgrades and strategic partnerships. Key risk factors include regulatory shifts, price pressure from biosimilar entrants, and potential disruptions in raw‑material logistics. Stakeholders should monitor these dynamics to capitalize on the Helicobacter Pylori Test Kit market outlook. Proactive portfolio diversification and early adoption of next‑generation assays will further enhance profitability.

12 items

1. Executive Summary

2. Helicobacter Pylori Test Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Helicobacter Pylori Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Helicobacter Pylori Test Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Helicobacter Pylori Test Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Helicobacter Pylori Test Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Helicobacter Pylori Test Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Helicobacter Pylori Test Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Helicobacter Pylori Test Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Helicobacter Pylori Test Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Helicobacter Pylori Test Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Helicobacter Pylori Test Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Helicobacter Pylori Test Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Helicobacter Pylori Test Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Helicobacter Pylori Test Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Helicobacter Pylori Test Kit Market Competition by Key Manufacturers

9.1. Global Helicobacter Pylori Test Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Helicobacter Pylori Test Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Abbott

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thermo Fisher

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BioMérieux

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bio-Rad Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. SEKISUI Diagnostics

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Enzo Biochem

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medline Industries

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Quidel

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Cardinal Health

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Agilent Technologies

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. DiaSorin

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Meridian Bioscience

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Biomerica

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Certest Biotec SL

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Alpha Laboratories

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Otsuka Pharmaceutical

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Eiken Chemical

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Savyon Diagnostics

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. BIOHIT HealthCare

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Serim Research

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Helicobacter Pylori Test Kit Market

Figure 4: Global Helicobacter Pylori Test Kit Market: Drivers

Figure 5: Global Helicobacter Pylori Test Kit Market: Challenges

Figure 6: Global Helicobacter Pylori Test Kit Market: Trends

Figure 7: Global Helicobacter Pylori Test Kit Market: Opportunity

Figure 8: Global Helicobacter Pylori Test Kit Market: Restraint

Figure 9: Global Helicobacter Pylori Test Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Helicobacter Pylori Test Kit Market Value (USD Million) By Region

Figure 19: Global Helicobacter Pylori Test Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Helicobacter Pylori Test Kit Market Value (USD Million) By Region

Figure 27: Global Helicobacter Pylori Test Kit Market Share (%) By: Regions (2032)

Figure 28: Global Helicobacter Pylori Test Kit Market Volume (K) By Region

Figure 29: Global Helicobacter Pylori Test Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Helicobacter Pylori Test Kit Market Value (USD Million) By Region

Figure 37: Global Helicobacter Pylori Test Kit Market Share (%) By: Regions (2032)

Figure 38: Global Helicobacter Pylori Test Kit Market Volume (K) By Region

Figure 39: Global Helicobacter Pylori Test Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

135 items

Table 1: Market Segmentation Analysis

Table 2: Global Helicobacter Pylori Test Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Helicobacter Pylori Test Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Helicobacter Pylori Test Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Helicobacter Pylori Test Kit Market Value (USD Million) By Region

Table 14: Global Helicobacter Pylori Test Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Helicobacter Pylori Test Kit Market Volume (K) By Region

Table 31: Global Helicobacter Pylori Test Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Helicobacter Pylori Test Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Helicobacter Pylori Test Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Helicobacter Pylori Test Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Abbott Basic Information And Sales Area

Table 52: Abbott. Products Portfolio

Table 53: Thermo Fisher Basic Information And Sales Area

Table 54: Thermo Fisher. Products Portfolio

Table 55: BioMérieux Basic Information And Sales Area

Table 56: BioMérieux. Products Portfolio

Table 57: Bio-Rad Laboratories Basic Information And Sales Area

Table 58: Bio-Rad Laboratories. Products Portfolio

Table 59: SEKISUI Diagnostics Basic Information And Sales Area

Table 60: SEKISUI Diagnostics. Products Portfolio

Table 61: Enzo Biochem Basic Information And Sales Area

Table 62: Enzo Biochem. Products Portfolio

Table 63: Medline Industries Basic Information And Sales Area

Table 64: Medline Industries. Products Portfolio

Table 65: Quidel Basic Information And Sales Area

Table 66: Quidel. Products Portfolio

Table 67: Cardinal Health Basic Information And Sales Area

Table 68: Cardinal Health. Products Portfolio

Table 69: Agilent Technologies Basic Information And Sales Area

Table 70: Agilent Technologies. Products Portfolio

Table 71: DiaSorin Basic Information And Sales Area

Table 72: DiaSorin. Products Portfolio

Table 73: Meridian Bioscience Basic Information And Sales Area

Table 74: Meridian Bioscience. Products Portfolio

Table 75: Biomerica Basic Information And Sales Area

Table 76: Biomerica. Products Portfolio

Table 77: Certest Biotec SL Basic Information And Sales Area

Table 78: Certest Biotec SL. Products Portfolio

Table 79: Alpha Laboratories Basic Information And Sales Area

Table 80: Alpha Laboratories. Products Portfolio

Table 81: Otsuka Pharmaceutical Basic Information And Sales Area

Table 82: Otsuka Pharmaceutical. Products Portfolio

Table 83: Eiken Chemical Basic Information And Sales Area

Table 84: Eiken Chemical. Products Portfolio

Table 85: Savyon Diagnostics Basic Information And Sales Area

Table 86: Savyon Diagnostics. Products Portfolio

Table 87: BIOHIT HealthCare Basic Information And Sales Area

Table 88: BIOHIT HealthCare. Products Portfolio

Table 89: Serim Research Basic Information And Sales Area

Table 90: Serim Research. Products Portfolio

Table 91: Global Market Value (USD Million) (2025-2032) By Type

Table 92: Global Market Share (%) By Type (2032)

Table 93: Global Market Value (USD Million) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Type

Table 96: Global Market Share (%) By Type (2032)

Table 97: Global Market Volume (K) (2025-2032) By Application

Table 98: Global Market Share (%) By Application (2032)

Table 99: Global Helicobacter Pylori Test Kit Market Value (USD Million) By Region

Table 100: Global Helicobacter Pylori Test Kit Market Share (%) By Region (2025-2032)

Table 101: North America Market Value (USD Million) (2025-2032) By Country

Table 102: North America Market Value (USD Million) (2025-2032) By Type

Table 103: North America Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Country

Table 105: Europe Market Value (USD Million) (2025-2032) By Type

Table 106: Europe Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 108: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 109: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Country

Table 111: South America Market Value (USD Million) (2025-2032) By Type

Table 112: South America Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 114: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 115: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 116: Global Helicobacter Pylori Test Kit Market Volume (K) By Region

Table 117: Global Helicobacter Pylori Test Kit Market Share (%) By Region (2025-2032)

Table 118: North America Market Volume (K) (2025-2032) By Country

Table 119: North America Market Volume (K) (2025-2032) By Type

Table 120: North America Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Country

Table 122: Europe Market Volume (K) (2025-2032) By Type

Table 123: Europe Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 125: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 126: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Country

Table 128: South America Market Volume (K) (2025-2032) By Type

Table 129: South America Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 131: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 132: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 133: Research Programs/Design For This Report

Table 134: Key Data Information From Secondary Sources

Table 135: Key Data Information From Primary Sources

FAQs

1. What is the current Helicobacter Pylori Test Kit market size?

As of 2023, the Helicobacter Pylori Test Kit market size is estimated at USD 1.2 billion, reflecting demand from gastro‑enterology clinics, hospitals, and point‑of‑care laboratories worldwide. The valuation incorporates both rapid antigen and molecular testing segments.

2. What is the projected growth forecast for the market?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2032, reaching roughly USD 1.9 billion by the end of the forecast period. Growth is driven by rising H. pylori prevalence and screening initiatives.

3. What are the key drivers behind market expansion?

Key drivers include increasing incidence of peptic‑ulcer disease, growing awareness of H. pylori‑related gastric cancer, government‑backed screening programs in Asia‑Pacific, and the shift toward non‑invasive, rapid diagnostic kits that support early treatment decisions in clinical pathways across healthcare systems.

4. What challenges could hinder market growth?

Challenges comprise stringent regulatory approvals for molecular kits, limited reimbursement in low‑income regions, competition from serology tests, and the need for cold‑chain logistics for certain reagents, which can increase operational costs for distributors throughout the supply chain.

5. Which regions are leading the Helicobacter Pylori Test Kit market?

North America holds the largest share due to advanced healthcare infrastructure, while Asia‑Pacific is the fastest‑growing region, driven by high H. pylori prevalence and expanding diagnostic networks in China, India, and Japan, and increasing government health initiatives.

6. Who are the top companies operating in this market?

Leading players include Abbott Laboratories, BioMérieux, Qiagen, Meridian Bioscience, and Siemens Healthineers, each offering a portfolio of rapid antigen, ELISA, and PCR‑based Helicobacter Pylori Test Kits that cater to hospital and point‑of‑care segments, globally and strategically positioned for growth.

7. What future opportunities are emerging for the market?

Future opportunities arise from integration of multiplex panels that detect H. pylori alongside other gastrointestinal pathogens, expansion into tele‑medicine diagnostics, and partnerships with pharmaceutical firms developing eradication therapies, which could boost kit adoption rates in emerging markets.

8. How is technology influencing the Helicobacter Pylori Test Kit market?

Advances such as real‑time PCR, microfluidic cartridges, and AI‑enhanced result interpretation are shortening turnaround times and improving sensitivity, enabling bedside testing and facilitating large‑scale screening programs that reshape market dynamics across both developed and developing healthcare settings.

9. What is the regulatory landscape for these test kits?

Regulatory frameworks vary: FDA clearance is required for U.S. distribution, while the EU mandates CE marking under IVDR. Asian markets often follow local health authority approvals, creating a multi‑layered compliance environment that manufacturers must navigate.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Helicobacter Pylori Test Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	520.00 million
Revenue forecast in 2033	906.90 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Abbott; Thermo Fisher; BioMérieux; Bio-Rad Laboratories; SEKISUI Diagnostics; Enzo Biochem; Medline Industries; Quidel; Cardinal Health; Agilent Technologies; DiaSorin; Meridian Bioscience; Biomerica; Certest Biotec SL; Alpha Laboratories; Otsuka Pharmaceutical; Eiken Chemical; Savyon Diagnostics; BIOHIT HealthCare; Serim Research
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options